A detailed history of Ziegler Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ziegler Capital Management, LLC holds 21,678 shares of AZN stock, worth $1.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
21,678
Previous 22,738 4.66%
Holding current value
$1.4 Million
Previous $1.53 Million 4.11%
% of portfolio
0.05%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $64,691 - $73,744
-1,060 Reduced 4.66%
21,678 $1.47 Million
Q4 2023

Jan 11, 2024

SELL
$61.89 - $69.28 $50,626 - $56,671
-818 Reduced 3.47%
22,738 $1.53 Million
Q3 2023

Oct 16, 2023

SELL
$64.85 - $71.7 $45,135 - $49,903
-696 Reduced 2.87%
23,556 $1.6 Million
Q2 2023

Jul 25, 2023

SELL
$69.91 - $75.81 $380,939 - $413,088
-5,449 Reduced 18.35%
24,252 $1.74 Million
Q1 2023

May 04, 2023

SELL
$63.15 - $71.6 $14,335 - $16,253
-227 Reduced 0.76%
29,701 $2.06 Million
Q4 2022

Jan 24, 2023

SELL
$54.21 - $70.44 $18,919 - $24,583
-349 Reduced 1.15%
29,928 $0
Q3 2022

Oct 25, 2022

SELL
$53.02 - $135.75 $14,103 - $36,109
-266 Reduced 0.87%
30,277 $1.66 Million
Q2 2022

Jul 21, 2022

SELL
$59.26 - $71.14 $41,067 - $49,300
-693 Reduced 2.22%
30,543 $2.02 Million
Q1 2022

May 04, 2022

BUY
$55.72 - $67.12 $429,155 - $516,958
7,702 Added 32.73%
31,236 $2.07 Million
Q4 2021

Feb 09, 2022

SELL
$54.02 - $63.83 $66,714 - $78,830
-1,235 Reduced 4.99%
23,534 $1.37 Million
Q3 2021

Oct 27, 2021

BUY
$55.56 - $60.79 $1.38 Million - $1.51 Million
24,769 New
24,769 $1.49 Million
Q2 2020

Jul 24, 2020

SELL
$43.1 - $55.31 $2.47 Million - $3.17 Million
-57,274 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$37.79 - $51.33 $2.16 Million - $2.94 Million
57,274 New
57,274 $2.56 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.